日韩亚洲一区中文字幕在线,欧美中文字幕无线码视频,亚洲欧美中文日韩二区一区,国产专区日韩精品欧美色,欧美国产日本精品一区二区三区|亚洲国产精品久久无码,欧美日韩综合中文字幕不卡三区,欧美日产精品一级免费

The TCM instant granules are expected to achieve rapid growth in the Chinese market. [Photo/VCG]

The traditional Chinese medicine (TCM) instant granules are expected to achieve rapid growth in the Chinese market.

"As the total scale of TCM market is more than 700 billion yuan in China while TCM instant granules is just around 11 billion, the market for TCM instant granules has huge room for growth," said Wei Mei, deputy general manager of Guangdong Yifang Pharmaceutical Co.

Guangdong Yifang is a subsidiary of Hong Kong-listed China Traditional Chinese Medicine Holdings Co which is the country's largest TCM instant granule producer. In 2017, the TCM instant granules business segment of China Traditional Chinese Medicine Holdings recorded about 5.5 billion yuan in revenue, growing at 26.2 percent year-on-year, and took up about half of the Chinese market by supplying to more than 3,000 Chinese hospitals.

Operating eight TCM instant granule production bases in seven provinces and plantation bases for more than 100 TCM herbs, Guangdong Yifang generated a revenue of over 3 billion yuan last year.

Guangdong Yifang's products were also exported last year to more than 30 countries and regions, worth about 45 million yuan for making food, dietary supplement and personal care products.

“We plan to have 26 TCM instant granule production bases in 23 provinces to boost our annual production capacity to 25,000 tons by 2022,” said Huang He, vice-president of China Traditional Chinese Medicine Holdings.